Cargando…
HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment
HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by antiretroviral agents. In fact, the prevalence of milder subtypes of cognitive impairment is increasing. Neuropsychologic testing remains the “gold standard” of diagnosis; however, this is time consum...
Autores principales: | Carroll, Antonia, Brew, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365228/ https://www.ncbi.nlm.nih.gov/pubmed/28413625 http://dx.doi.org/10.12688/f1000research.10651.1 |
Ejemplares similares
-
Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder
por: Davies, Nicholas W.S., et al.
Publicado: (2010) -
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
por: Eggers, Christian, et al.
Publicado: (2017) -
HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities
por: Lindl, Kathryn A., et al.
Publicado: (2010) -
Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders
por: Liu, Han, et al.
Publicado: (2016) -
MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a review
por: Chaganti, Joga, et al.
Publicado: (2021)